ArticleCancer medicine2023

Does first-line treatment have prognostic impact for unresectable HCC?-Atezolizumab plus bevacizumab versus lenvatinib.

Atsushi Hiraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.